leisure time -WSS

leisure time

author：explore 2025-09-03 05:29:20 - browse：75889

Truvian Health employee with a plate holding reagents used to measure commonly tested blood markers. Truvian

SAN DIEGO — Truvian Health, a San Diego blood diagnostics company, shared data on Tuesday showing that its benchtop instrument’s results are largely consistent with those generated by large central laboratories. But while the results lend support for the company’s vision of decentralized and widely available clinical testing, they also resurface questions about the value of an approach widely associated with the now defunct and notorious Bay Area startup Theranos.

In a multisite study, the company tested nearly 240 blood samples from healthy donors and chronic disease patients for dozens of blood-based measurements commonly ordered by doctors, from cholesterol to blood sugar to blood cell counts. Results from Truvian’s benchtop analytical instrument, with few exceptions, closely matched readings from devices used in large central labs and made by Swiss pharma giant Roche and Japanese firm Sysmex.

The findings were presented at the annual meeting of the American Association for Clinical Chemistry, recently rebranded as the Association for Diagnostics & Laboratory Medicine. It’s the first time Truvian has shared clinical data on its product, though they have not been published in a peer-reviewed journal. The company, which is planning additional validation studies, expects to submit for Food and Drug Administration approval of its device by the third quarter of 2024.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： How AI helped researchers track recovery from depression

hotspot

WSS

Lindsay Lohan welcomes 1st child with husband Bader Shammas

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

Biotech stock slump in 2023: awaiting the turnaround

Norman Reedus' Daryl Dixon

Medical experts are missing from AI regulatory conversations

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

focus

leisure time

leisure time

What does generative AI mean for health care? We asked experts

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

The cancer drug shortage isn’t new — and neither are the solutions

How AI helped researchers track recovery from depression

Medical leaders decry Supreme Court decision on affirmative action

Microbiome research is starting to find links to chronic diseases

Alkermes shareholders re

Stanford president to resign after investigation of research

Sports medicine is finally prioritizing gender equality

Norman Reedus' Daryl Dixon

knowledge

Couple fighting to bring baby home from Mexico are finally reunited

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Norman Reedus' Daryl Dixon

Trump got a 'target letter.' What is one and what does it mean?

Stanford updates investigation of president’s past research

Why are Kaiser Permanente staff considering a strike?

hotspot

explore

hotspot

explore